Crowdfunding Democratizes Biotechnology Investment Access Biotechnology investment has traditionally been restricted to institutional investors and accredited individuals meeting substantial net worth requirements. Recent regulatory changes and digital platforms are beginning to democratize access, allowing retail investors to participate in early-stage cellular therapy development. Equity crowdfunding platforms enable companies to raise […]